Rosalind Advisors, Inc. - 31 Dec 2025 SCHEDULE 13G/A Report for MediWound Ltd. Common Shares (MDWD)

Filing Manager
Rosalind Advisors, Inc.
Reporting Manager
Rosalind Advisors, Inc.
Symbol
MDWD
Shares outstanding
13,033,129 shares
Disclosed Ownership
912,319 shares
Ownership
7%
Form type
SCHEDULE 13G/A
Filing time
11 Feb 2026, 12:59:01 UTC
Date of event
31 Dec 2025
Previous filing
12 Nov 2025

Quoteable Key Fact

"Rosalind Advisors, Inc. disclosed 7% ownership in MediWound Ltd. Common Shares (MDWD) on 31 Dec 2025."

Quick Takeaways

  • Rosalind Advisors, Inc. filed SCHEDULE 13G/A for MediWound Ltd. Common Shares (MDWD).
  • Disclosed ownership: 7%.
  • Date of event: 31 Dec 2025.

What Changed

  • Previous schedule filing date: 12 Nov 2025.
  • Current filing was accepted on 11 Feb 2026, 12:59.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Rosalind Advisors, Inc. 7% 912,319 0 912,319 Steven Salamon President
SALAMON STEVEN A J 7% 912,319 0 912,319 Steven Salamon Steven Salamon
Aharon Gil 7% 912,319 0 912,319 Aharon Gil Aharon Gil
Rosalind Master Fund L.P. 7% 912,319 0 912,319 Mike McDonald Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund)
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .